Skip to main content

Knee Osteoarthritis

55
Pipeline Programs
30
Companies
50
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
8
2
19
0
19
7
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
240%
Small Molecule
240%
Peptide
120%
+ 177 programs with unclassified modality

Competitive Landscape

85 companies ranked by most advanced pipeline stage

Zimmer Biomet
13 programs
1
ROSA PSA Parapatellar ApproachPhase 41 trial
Cementless Vanguard DD RPN/A1 trial
Comparison of Functional Outcomes of Three Surgical Approaches in Knee ArthroplastyN/A1 trial
High-Flexion Knee Replacement System using Cemented FixationN/A1 trial
MC polyethylene bearingN/A1 trial
+8 more programs
Active Trials
NCT04076202Active Not Recruiting113Est. Dec 2026
NCT00983762Terminated12Est. Jan 2020
NCT01194817Active Not Recruiting100Est. Dec 2026
+10 more trials
Regen Lab
5 programs
1
hyaluronic Acid + platelet-rich plasmaPhase 41 trial
A-CP HA KitN/A1 trial
Cellular Matrix / A-CP HAN/A1 trial
Cellular Matrix / A-CP HA KitN/A1 trial
Regen Matrix-PRP-XLHAN/A1 trial
Active Trials
NCT03201614Unknown290Est. Apr 2022
NCT02964143Unknown306Est. Dec 2020
NCT03328728Unknown190Est. Mar 2021
+2 more trials
Spine BioPharma
4 programs
1
BiofreezePhase 41 trial
Dorsal Root Ganglion StimulationN/A
HAM and HUMCWJ InjectionsN/A1 trial
Pulse RadiofrequencyN/A1 trial
Active Trials
NCT03337243Completed60Est. Apr 2019
NCT04238598Completed30Est. Sep 2021
NCT03888807Terminated6Est. Jul 2024
Ache Laboratorios Farmaceuticos
2
1
Curcuma Longa Extract + PhosphatidylcholinePhase 4
Glucosamine Sulfate + Chondroitin SulfatePhase 3
glucosamine sulfate /chondroitin sulfate - capsulesPhase 31 trial
Active Trials
NCT02010918Completed922Est. Nov 2010
Dr. Reddy's Laboratories
2 programs
1
NISEPhase 41 trial
NISELATN/A1 trial
Active Trials
NCT02865161Completed220Est. Dec 2015
NCT02922712Completed202Est. Aug 2013
Pfizer
PfizerNEW YORK, NY
2 programs
1
1
celecoxibPhase 4Small Molecule1 trial
SD-6010Phase 31 trial
Active Trials
NCT01438918Withdrawn0Est. Dec 2015
NCT00194090Completed40Est. Sep 2005
RS Research
1 program
1
Patterned Electrical Neuromuscular StimulationPhase 41 trial
Active Trials
NCT00701506Completed13Est. Nov 2010
Biocorp
6 programs
1
2
JOINTSTEMPhase 3
Standard PhysiotherapyPhase 31 trial
JointstemPhase 2
Rapid Recovery Rehabilitation ProgrammeN/A1 trial
Total Knee ArthroplastyN/A1 trial
+1 more programs
Active Trials
NCT04155957Completed52Est. Dec 2020
NCT06634654Recruiting197Est. Dec 2029
NCT06726629Recruiting200Est. Nov 2026
+1 more trials
Anika Therapeutics
3
CingalPhase 31 trial
CingalPhase 31 trial
Sodium HyaluronatePhase 31 trial
Hyaluronic Acid and THN/A1 trial
Sodium HyaluronateN/A
Active Trials
NCT01891396Completed368Est. Sep 2014
NCT03191903Completed576Est. Apr 2018
NCT03390036Completed526Est. Jul 2018
+1 more trials
Galderma
4 programs
1
1
1
Durolane is a device, methylprednisolone in a drugPhase 31 trial
Durolane 3 ml, Durolane 4,5 ml, Durolane 6 mlPhase 21 trial
Botulinum toxinPhase 11 trial
DurolaneN/A1 trial
Active Trials
NCT01753830Terminated75Est. Feb 2014
NCT02139319Completed22Est. Jul 2014
NCT01265459Completed68Est. Nov 2011
+1 more trials
Biomed
3 programs
1
1
1
ELIXCYTEPhase 31 trial
Elixcyte 8 mlPhase 1/21 trial
BBM-A101Phase 1
Active Trials
NCT02784964Completed57Est. Jun 2021
NCT05526001Active Not Recruiting165Est. Nov 2026
Sandoz
SandozAustria - Kundl
3 programs
2
1
LumiracoxibPhase 3Small Molecule
balicatibPhase 2
canakinumabPhase 2Monoclonal Antibody
Centrexion Therapeutics
1
1
CNTX-4975-05Phase 31 trial
CNTX-4975-05Phase 11 trial
Active Trials
NCT03576508Completed16Est. Sep 2018
NCT03661996Completed854Est. Oct 2019
R-Bio
2 programs
1
1
JOINTSTEMPhase 31 trial
JointstemPhase 21 trial
Active Trials
NCT03509025Completed11Est. Dec 2020
NCT04427930Active Not Recruiting129Est. Dec 2027
Lipogems International
2
Microfragmented Adipose TissuePhase 31 trial
Microfragmented Adipose Tissue derived using the Lipogems® SystemPhase 31 trial
Active Trials
NCT05660772Completed173Est. Apr 2025
NCT06121882Active Not Recruiting173Est. Jun 2025
Cell Technologies
1
Autologous Bone Marrow Aspirate ConcentratePhase 31 trial
Active Trials
NCT06216028Not Yet Recruiting374Est. Dec 2026
Hanlim Pharm
1 program
1
Enteron tab. 150mgPhase 31 trial
Active Trials
NCT01768520Completed338Est. May 2015
PharmaResearch
1
NPNP-001Phase 31 trial
Active Trials
NCT06779071Enrolling By Invitation260Est. Jun 2026
Doron Therapeutics
1
PTP-01Phase 31 trial
Active Trials
NCT07219771Recruiting260Est. Oct 2027
Innovation Pharmaceuticals
1
Knee Pain Ejiao PastePhase 21 trial
ATTUNE PS KneeN/A1 trial
Digital decision aid for physicians and patientsN/A1 trial
Simultaneous Knee ArthroplastyN/A1 trial
Active Trials
NCT03554720Completed50Est. Jan 2024
NCT04837053Completed1,092Est. Apr 2024
NCT03564730Active Not Recruiting224Est. Dec 2026
+1 more trials
AbelZeta Pharma
3 programs
1
2
Autologous adipose tissue-derived cellsPhase 2
Mesenchymal progenitor cellsPhase 23 trials
Mesenchymal stem cells low-dose groupPhase 1/21 trial
Active Trials
NCT01809769Completed18Est. Jul 2015
NCT04208646Completed106Est. Jul 2023
NCT02641860Completed22Est. Mar 2018
+1 more trials
Prevail Therapeutics
1
TeriparatidePhase 2Peptide
99mTc-EC20N/A
OrthoTrophix
2 programs
2
TPX-100 200 mg 4 times weekly for 4 weeksPhase 21 trial
TPX-100 50mgPhase 21 trial
Active Trials
NCT02837900Completed14Est. Aug 2017
NCT01925261Completed120Est. Sep 2016
4Moving Biotech
1
4P004Phase 22 trials
Active Trials
NCT07225829Recruiting129Est. Sep 2026
NCT05419856Completed34Est. Oct 2023
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
ABT-981Phase 21 trial
Active Trials
NCT02087904Completed350Est. Dec 2016
Chong Kun Dang Pharmaceutical
1
CKD-981Phase 21 trial
Active Trials
NCT06954766Completed100Est. Oct 2025
MSD
MSDIreland - Ballydine
1 program
1
ControlPhase 21 trial
Active Trials
NCT01246362Completed65Est. Jan 2014
Sharp Therapeutics
1
ControlPhase 2
Menarini
1 program
1
Fasitibant- low dosePhase 21 trial
Active Trials
NCT02205814Completed436Est. Jan 2015
Medica Corp
1 program
1
Stromal-vascular fractionPhase 2

+55 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Zimmer BiometROSA PSA Parapatellar Approach
Spine BioPharmaBiofreeze
Regen Labhyaluronic Acid + platelet-rich plasma
Ferring PharmaceuticalsEuflexxa
SanofiHylan G-F 20
BioibericaChondroitin/Glucosamine
Dr. Reddy's LaboratoriesNISE
BioibericaChondroitin sulphate
SanofiHylan G-F 20
RS ResearchPatterned Electrical Neuromuscular Stimulation
SanofiHylan G-F 20
Pfizercelecoxib
Doron TherapeuticsPTP-01
PharmaResearchNPNP-001
Cell TechnologiesAutologous Bone Marrow Aspirate Concentrate

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 12,983 patients across 50 trials

NCT06267482Zimmer BiometROSA PSA Parapatellar Approach

Using ROSA for Challenging The TKA Standard of Care

Start: Apr 2024Est. completion: Dec 202590 patients
Phase 4Recruiting

Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain

Start: Mar 2018Est. completion: Jul 20246 patients
Phase 4Terminated
NCT03211650Regen Labhyaluronic Acid + platelet-rich plasma

Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis

Start: Oct 2016Est. completion: Mar 2021174 patients
Phase 4Completed

To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection

Start: Aug 2013Est. completion: Jan 201712 patients
Phase 4Completed
NCT01586338SanofiHylan G-F 20

A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)

Start: Mar 2012Est. completion: Sep 2013237 patients
Phase 4Completed
NCT01425853BioibericaChondroitin/Glucosamine

Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis

Start: Sep 2011Est. completion: May 2013606 patients
Phase 4Completed

Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis)

Start: Mar 2011Est. completion: Aug 2013202 patients
Phase 4Completed
NCT01226615BioibericaChondroitin sulphate

Assessment of the Effects of Chondroitin Sulphate in Patients With Knee Osteoarthritis With Functional Magnetic Resonance Imaging (fMRI)

Start: Oct 2010Est. completion: Dec 201264 patients
Phase 4Unknown
NCT02389452SanofiHylan G-F 20

Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment

Start: Feb 2010Est. completion: Sep 2011394 patients
Phase 4Completed
NCT00701506RS ResearchPatterned Electrical Neuromuscular Stimulation

Patterned Electrical Neuromuscular Stimulation and Therapeutic Exercise for Osteoarthritis of the Knee: Pilot Study

Start: May 2008Est. completion: Nov 201013 patients
Phase 4Completed
NCT00393393SanofiHylan G-F 20

Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee

Start: Jan 2006Est. completion: Jan 200680 patients
Phase 4Unknown

Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk

Start: Jun 2004Est. completion: Sep 200540 patients
Phase 4Completed

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients

Start: Oct 2025Est. completion: Oct 2027260 patients
Phase 3Recruiting

Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.

Start: Jan 2025Est. completion: Jun 2026260 patients
Phase 3Enrolling By Invitation
NCT06216028Cell TechnologiesAutologous Bone Marrow Aspirate Concentrate

Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis

Start: Sep 2024Est. completion: Dec 2026374 patients
Phase 3Not Yet Recruiting
NCT06121882Lipogems InternationalMicrofragmented Adipose Tissue derived using the Lipogems® System

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

Start: Mar 2024Est. completion: Jun 2025173 patients
Phase 3Active Not Recruiting
NCT05632783IBSA Institut BiochimiqueChondroitin Sulfate Sodium

TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study

Start: Dec 2023Est. completion: Jul 20260
Phase 3Withdrawn
NCT06000410OrganogenesisAmniotic Suspension Allograft

A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Start: Sep 2023Est. completion: Nov 2025594 patients
Phase 3Completed

Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis

Start: Jul 2023Est. completion: Nov 2026165 patients
Phase 3Active Not Recruiting
NCT05660772Lipogems InternationalMicrofragmented Adipose Tissue

Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis

Start: Dec 2022Est. completion: Apr 2025173 patients
Phase 3Completed

A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES)

Start: Nov 2022Est. completion: Feb 2024496 patients
Phase 3Completed
NCT04636229OrganogenesisAmniotic Suspension Allograft

Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Start: Dec 2020Est. completion: Aug 2025516 patients
Phase 3Completed

Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)

Start: May 2020Est. completion: Sep 2021496 patients
Phase 3Completed

Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

Start: Apr 2020Est. completion: Dec 2027129 patients
Phase 3Active Not Recruiting

Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis

Start: May 2019Est. completion: Aug 2021501 patients
Phase 3Completed

An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA

Start: Sep 2018Est. completion: Oct 2019854 patients
Phase 3Completed

Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up

Start: Dec 2017Est. completion: Jul 2018526 patients
Phase 3Completed
NCT03200288IBSA Institut BiochimiqueHL-01: high and low molecular weight hyaluronic acid

A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis

Start: Jun 2017Est. completion: Oct 2018692 patients
Phase 3Completed

Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

Start: May 2017Est. completion: Apr 2018576 patients
Phase 3Completed

Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA

Start: Jun 2014Est. completion: Jun 2016604 patients
Phase 3Completed
NCT01768520Hanlim PharmEnteron tab. 150mg

Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee

Start: Jul 2012Est. completion: May 2015338 patients
Phase 3Completed

X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee

Start: Mar 2012Est. completion: Dec 20150
Phase 3Withdrawn
NCT01354145BioibericaChondroitin sulfate

Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI

Start: Jun 2011Est. completion: Oct 2014194 patients
Phase 3Completed
NCT01096524BiocorpStandard Physiotherapy

Effects of Kneehab 12-week Peri-operative Total Knee Arthroplasty

Start: Mar 2010Est. completion: Jun 2014200 patients
Phase 3Completed
NCT02010918Ache Laboratorios Farmaceuticosglucosamine sulfate /chondroitin sulfate - capsules

Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

Start: Feb 2009Est. completion: Nov 2010922 patients
Phase 3Completed
NCT01209364GaldermaDurolane is a device, methylprednisolone in a drug

Durolane Versus Methylprednisolone in Knee Osteoarthritis

Start: Mar 2007Est. completion: Nov 2008442 patients
Phase 3Completed
NCT00131352SanofiHylan G-F 20

A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee

Start: May 2005Est. completion: Sep 2006253 patients
Phase 3Completed
NCT00131300SanofiHylan G-F 20

A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis

Start: Apr 2004Est. completion: Feb 2006
Phase 3Completed
NCT00131326SanofiHylan G-F 20

A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip

Start: Nov 2003Est. completion: Apr 2006
Phase 3Completed
NCT00131768SanofiHylan G-F 20

A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis

Start: Nov 2003Est. completion: Feb 2006
Phase 3Completed

Knee Pain Ejiao Paste for Knee Osteoarthritis

Start: Mar 2026Est. completion: Dec 202860 patients
Phase 2Not Yet Recruiting

A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

Start: Jun 2025Est. completion: Sep 2026129 patients
Phase 2Recruiting

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

Start: Apr 2025Est. completion: Oct 2025100 patients
Phase 2Completed

Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

Start: Mar 2023Est. completion: Nov 202784 patients
Phase 2Active Not Recruiting

Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

Start: Feb 2022Est. completion: Oct 202394 patients
Phase 2Completed
NCT04208646AbelZeta PharmaMesenchymal progenitor cells

Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis

Start: May 2020Est. completion: Jul 2023106 patients
Phase 2Completed
NCT04050111Century TherapeuticsStromal-vascular fraction

The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis

Start: Aug 2019Est. completion: Aug 202130 patients
Phase 2Unknown

MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis

Start: Mar 2019Est. completion: Dec 202013 patients
Phase 2Terminated

A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

Start: Apr 2017Est. completion: Apr 2018700 patients
Phase 2Completed

Follow-up Study for Participants Jointstem Clinical Trial

Start: Feb 2017Est. completion: Dec 202011 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

19 late-stage (Phase 3) programs, potential near-term approvals
3 actively recruiting trials targeting 12,983 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.